Passkey

Cambridge, United States

Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs).

$20.0M raised

Oct 2024

Seed

Top Investors

Breakout VenturesBison VenturesAlexandria Venture InvestmentsGRIDS CapitalInnovation Endeavors

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Passkey raised?

Passkey has raised $20.0M in total funding. The most recent round was Seed. The last funding was announced in October 2024.

Who are Passkey's investors?

Passkey's investors include Breakout Ventures, Bison Ventures, Alexandria Venture Investments, GRIDS Capital, Innovation Endeavors.

Where is Passkey headquartered?

Passkey is headquartered in Cambridge, United States.

What does Passkey do?

Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs).

What stage is Passkey at?

Passkey is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 22, 2024.

MLA

"Passkey — Funding & Investors." VCBacked, October 22, 2024, https://www.vcbacked.co/company/passkey. Accessed June 4, 2026.

APA

VCBacked. (2024). Passkey — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/passkey

Wikipedia (cite web)

{{cite web |title=Passkey — Funding & Investors |url=https://www.vcbacked.co/company/passkey |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 22, 2024.